SIGHT SCIENCES, INC. (SGHT) Gross Margin
- Gross margin · 12 months: Value 87.96%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 87.96% | Gross profit / revenue. Period ending 2026-06-30. $73.34M ÷ $83.38M × 100 ≈ 87.96% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 73.34M USD | Gross Profit |
| Revenue | 83.38M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 10.04M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $73.34M | $83.38M | $10.04M | 87.96% |
| 2026-03-31 | $68.55M | $79.55M | $11.00M | 86.17% |
| 2025-12-31 | $66.67M | $77.36M | $10.70M | 86.17% |
| 2025-09-30 | $65.44M | $76.05M | $10.61M | 86.05% |
| 2025-06-30 | $65.15M | $76.30M | $11.15M | 85.38% |
| 2025-03-31 | $66.91M | $78.11M | $11.20M | 85.66% |
| 2024-12-31 | $68.28M | $79.87M | $11.58M | 85.50% |
| 2024-09-30 | $67.70M | $79.54M | $11.84M | 85.11% |
| 2024-06-30 | $68.12M | $79.39M | $11.27M | 85.80% |
| 2024-03-31 | $69.87M | $81.50M | $11.63M | 85.73% |
| 2023-12-31 | $69.17M | $81.06M | $11.88M | 85.34% |
| 2023-09-30 | $70.08M | $82.85M | $12.77M | 84.59% |
| 2023-06-30 | $68.49M | $81.52M | $13.02M | 84.03% |
| 2023-03-31 | $62.90M | $75.27M | $12.38M | 83.56% |
| 2022-12-31 | $58.97M | $71.33M | $12.36M | 82.67% |
| 2022-09-30 | $54.84M | $65.47M | $10.64M | 83.75% |
| 2022-06-30 | $50.13M | $59.90M | $9.77M | 83.69% |
| 2022-03-31 | $45.86M | $55.20M | $9.34M | 83.08% |
| 2021-12-31 | $40.35M | $48.96M | $8.61M | 82.41% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) |
| 2020-12-31 | $18.43M | $27.64M | $9.21M | 66.68% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |